위암종에서 ras 유전자 돌연변이와 ERK1, ERK2 단백의 발현
Ras Gene Mutations and Expression of ERK1 and ERK2 Proteins in Stomach Cancer
유진영, 강창석, 강석진, 김병기,
소속 상세정보
유진영 ( Yoo Jin-Young )
가톨릭대학교 의과대학 임상병리학교실
강창석 ( Kang Chang-Suk )
가톨릭대학교 의과대학 임상병리학교실
강석진 ( Kang Seok-Jin )
가톨릭대학교 의과대학 임상병리학교실
김병기 ( Kim Byung-Kee )
가톨릭대학교 의과대학 임상병리학교실
KMID : 0357920020360020077
Abstract
Background: We investigated stomach cancers for ras abnormalities and expression of ERK1 and ERK2 to determine their significance in the tumor development and/or progression and to evaluate their potential correlation with clinicopathologic parameters.
Methods: Seventy gastric adenocarcinomas were studied immunohistochemically in paraffin-embedded tissue sections for the expression of ERK1 and ERK2 proteins. All tumors were further analyzed with the use of a polymerase chain reaction technique and a direct sequence analysis procedure for the presence of the mutated ras gene.
Results: ERK1 and/or ERK2 was expressed in 65.7%(46/70) of the tumors; overexpression of ERK1 was observed in 38 (54.3%) tumors, whereas ERK2 was detected in 29 (41.4%). Nine (12.8%) samples demonstrated mutations in the rs gene: 4 in H-ras and 5 in K-ras. Seven of the 9(77.8%) mutated tumors were of the intestinal type. No assocition was established between the ras abnormatilites and the overexpression of ERK1 and/or ERK2. However, the correlation between ERK2 and progressio (early vs. advanced) was statistically significant (p<0.05).
Conclusions: These data indicate that ras abnormalities are uncommon events in gatstric adenocarcinomas. The majority of ras mutations, however, occurred in intestinal-type tumors, supporting the notion of different molecular mechanisms involved between the intestinal- and diffuse-type lesions. Enhanced ERK2 activity may provide assistance in the determinatino of tumor penetration in these tumors.
키워드
Stomach Neoplasms-Genes;ras-MAP Kinase Signaling System
원문 및 링크아웃 정보
등재저널 정보